Illumina is dedicated to advancing how we predict heritable diseases with the goal of improving early clinical intervention, treatments, and outcomes. We are committed to enabling groundbreaking research that will help populations across all ethnic backgrounds, genders, and social boundaries, large or small.
Eligible applicants are invited to submit an abstract (maximum of 400 words) for a new project describing the use of the Infinium Global Diversity Array with PRS Content-8 v1.0 Kit along with the Illumina Polygenic Risk Score software–Predict module.
Utilize existing scores or ones newly created to generate calculations and risk predictions for a disease or phenotype of interest, with eloquent reporting capabilities to further your research.
Applications for the 2023 Illumina Polygenic Risk Scores Research Grant Contest are being accepted. The deadline for all submissions is 11:59 PM PT on July 31, 2023.
One winner will be selected from all qualified applications by a panel of experts, who will rank the applications based on the following criteria:
The winner will receive 1008 samples of the Infinium Global Diversity Array with PRS Content-8 v1.0 Kit and accompanying analysis software, valued at over $100,000 USD (Prize). Research proposals that consider biomedical diversity will be prioritized.
In 400 words or less, provide an overview, a statement of work, and a description of the impact of your research. You may also include up to three figures, with legends, and a list of citations (with 200 word count limit). For more details, read the complete eligibility terms and conditions.
A team of scientists and executives will judge all submissions. Each submission will be judged based on our view of how well the entry reflects scientific merit, innovation, and fit with the values of Illumina.
Dr. Emma Johnson, PhD
Washington University, School of Medicine, St. Louis, MO
Learn more about polygenic risk scores and how they can help empower awareness about an individual's heritable risk of complex diseases.
In this on-demand webinar, Dr. Estelle Giraud provides an overview on why polygenic risk scores are clinically relevant and how they may be used in the future.
Illumina Polygenic Risk Score software is a user-friendly research solution that accelerates the complex polygenic risk score (PRS) development process while reducing the need for technical expertise.